Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cancer Risk and Biomarkers of Tamoxifen Chemoprevention
NCT00295100Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by University of Pennsylvania. Started Sep 2000; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00295100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295100.